Fig. 8.
Effect of adult IESCs on serum levels of gut proteins/metabolites and cytokines. Serum LPS, GFAP and IL-17A levels in the acute phase (4d) of stroke (a) and serum LPS and IL-17A in the chronic phase of stroke (b). Histograms depict mean ± SEM for each analyte in females (top panel) and males (bottom panel), n = 5–8/group/sex. a, Main effect of stroke; b, Main effect of treatment; c, interaction effect (time and treatment), *p < 0.01.
